Prostate-specific antigen-based screening

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Funders: KWF Kankerbestrijding and 1 more
  • Human trial1

Associations

1

Prostate cancer-specific mortality

downin humans1RR 0.77

1 study
  1. Prostate-specific antigen-based screening lowers the risk of prostate cancer-specific mortality in humans (RR 0.77, 95% CI 0.69-0.85).

    Human trial20 yrmalesn = 161,380

    Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer

    European urology open science30 Jul 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months